[Geuvadis_rnaseq] Geuvadis RNAseq Nature paper online publication

Dear all, The Geuvadis RNAseq Nature paper has been scheduled for advance online publication on September 15 at 1800 London time, 1900 CET, which is the time the embargo is lifted. A couple of points about the media strategy: - The international press release: we're coordinating this together with UNIGE and EBI/EMBL press offices - Local press releases: those of you who are planning to send out a local PR, please make sure that: 1) your press office receives the instructions from the Nature press office (copypasted below) and the embargo is respected, 2) your press release is distributed only nationally, and 3) you send a copy of your press release to me, Manolis and Gabrielle. - Social media: after the embargo is lifted, you're free (and encouraged) to advertise the paper on twitter, facebook, your website/blog, etc. On twitter, please use hashtag #geuvadis; I'll be posting under @tuuliel. - If you come across any substantial criticism or questions regarding the paper in the blogosphere or elsewhere, please let me and Manolis know so that we can formulate a response together. best regards, Tuuli Your paper 'Transcriptome and genome sequencing uncovers functional variation in humans' has been *scheduled for Advance Online Publication (AOP) on http://www.nature.com/nature <http://www.nature.com/nature> on 15 September 2013 at 1800 London time / 1300 US Eastern Time*. The embargo will lift at this time. Please forward this information to any co-authors. Papers published online before they have been allocated to a print issue will be citable via a digital object identifier (DOI) number. The DOI for your paper will be 10.1038/nature12531. Once the paper is published electronically, the DOI can be used to retrieve the abstract and full text from the /Nature/ web site (abstracts are available to everyone, full text only to subscribers) by adding it to the following URL: http://dx.doi.org/ . On the Tuesday before publication, /Nature/ distributes a press release highlighting papers of general interest. Journalists are given the name of the author(s) to contact, together with phone numbers and e-mail addresses. Journalists are also given online access not only to the papers on the press release but to all the papers due to appear in that issue. This means that your work could well receive media interest even if not featured on the press release, so it would be helpful if you (as corresponding author, we would, as a matter of course, put your name and affiliation on our press release as a contact, and attribute the work to you plus colleagues, so please let me know if this would not be appropriate) or a colleague could be available to answer any inquiries in the days leading up to publication. You are free to discuss your paper with the media, but we ask you to do this no more than five days before the publication date, and to ensure that /Nature's/ embargo conditions are understood by journalists and others. /Nature/ reserves the right to halt the publication of a paper if these conditions are broken. Journalists are permitted to show papers to independent specialists a few days in advance of publication, under embargo conditions, solely for the purpose of commenting on the work described. Wire services stories must always carry the embargo time at the head of each item, and may not be sent out more than 24 hours before that time. Journalists should credit /Nature/ as the source of stories covered. If you need further clarification about anything related to publicity, please contact one of the /Nature/ offices, as indicated below: /For North America and Canada/ Neda Afsarmanesh (/Nature/, New York) Tel: +1 212 726 9231; E-mail: n.afsarmanesh(a)us.nature.com <mailto:n.afsarmanesh@us.nature.com> /For Japan, Korea, China, Singapore and Taiwan/ Eiji Matsuda (/Nature/, Tokyo) Tel: +81 3 3267 8751; E-mail: e.matsuda(a)natureasia.com <mailto:e.matsuda@natureasia.com> /For the UK/ Rebecca Walton (/Nature/, London) Tel: +44 20 7843 4502; E-mail: r.walton(a)nature.com <mailto:r.walton@nature.com> Rachel Twinn (/Nature/, London) Tel: +44 20 7843 4658; E-mail: r.twinn(a)nature.com <mailto:r.twinn@nature.com> If you are reporting sequence or structural data with an accession code for a public database, we request you to set the release into the public domain upon receipt of this letter. This will allow our editors to test the link from the journal website to the database in readiness for the date of publication of your article. For authors reporting protein structures, release of the coordinates now will also allow us to set up a three-dimensional view window within the online version of the article. For any queries concerning proofs or corrections, please contact the Editorial Production department in London. You and your coauthors, or your institutions, can also order copies of the issue of /Nature/ containing your article: please contact g.painter(a)nature.com <mailto:g.painter@nature.com>, stating the publication reference and the number of copies required. If you and your coauthors are not subscribers to /Nature/ and would like to subscribe, please contact subscriptions(a)nature.com and ask for details of special prices for published /Nature/ authors. On /24/713 10:49 AM, Tuuli Lappalainen wrote: -- Tuuli Lappalainen, PhD Department of Genetics, Stanford University School of Medicine Email: tuuli.e.lappalainen(a)gmail.com Tel: +1 415 351 9713 Bustamante lab Department of Genetics 300 Pasteur Dr. Lane L301 Stanford, CA 94305-5120 USA